U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 26

Tests names and labsConditionsGenes, analytes, and microbesMethods

Infertility Panel

Centogene AG - the Rare Disease Company
Germany
243238
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoScreen

Centogene AG - the Rare Disease Company
Germany
316314
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

LHCGR - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Disorders of Sex Development Panel

Invitae
United States
8853
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320, Autosomal recessive (Leydig cell hypoplasia) (LHCGR gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Luteinizing hormone resistance, female, 238320, Autosomal recessive (Leydig cell hypoplasia) (LHCGR gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Ambiguous Genitalia Panel

PreventionGenetics, part of Exact Sciences
United States
12885
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

LHCGR-related Disorders via the LHCGR Gene

PreventionGenetics, part of Exact Sciences
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Infertility

Genologica Medica
Spain
2511
  • C Sequence analysis of the entire coding region

Panel of premature ovarian failure. NGS panel of 15 genes.

Genologica Medica
Spain
5015
  • C Sequence analysis of the entire coding region

Genital Abnormalities / Sex Development Disorders Panel

Genologica Medica
Spain
9549
  • C Sequence analysis of the entire coding region

Leydig Cell Hypoplasia (LHCGR Single Gene Test)

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Male Infertility NGS Panel

Fulgent Genetics
United States
7945
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Familial Male-Limited Precocious Puberty (LHCGR Single Gene Test)

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Infertility NGS Panel

Fulgent Genetics
United States
9256
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Female Infertility NGS Panel

Fulgent Genetics
United States
7641
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Leydig Cell Hypoplasia , Sequencing Exon 11 LHCGR Gene

Reference Laboratory Genetics
Spain
11
  • E Sequence analysis of select exons

Leydig Cell Hypoplasia , Sequencing LHCGR Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Leydig cell agenesis

Labor Dr. Wisplinghoff
Germany
11
  • C Sequence analysis of the entire coding region

STON1-GTF2A1L Single Gene

Fulgent Genetics
United States
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 26

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.